To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Morphinone is itself not a very potent opioid but it is the intermediate when morphine is being converted to hydromorphone (trade name Dilaudid®) which is 4-6 times as potent as morphine. Dilaudid is generally used only in palliative care or for pain in individuals who are already tolerant to opiates. In the United Kingdom, Dilaudid is marketed as Palladone® and Palladone SR®. The equivalent of Palladone SR® was removed from the US market when it was discovered that mixing alcohol with the sustained release capsules could cause the whole dose to be released at once, often with fatal consequences.
Morphinone itself is an active opiate although its potency is closer to codeine than morphine. It is, however, an important precursor and would fall under the purview of the Controlled Substances Act within the United States. Its legal status in other countries varies.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Morphinone". A list of authors is available in Wikipedia.|